Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Other financing activities (2016 - 2019)

Historic Other financing activities for Sunshine Biopharma (SBFM) over the last 7 years, with Q4 2019 value amounting to $7590.0.

  • Sunshine Biopharma's Other financing activities fell 9892.43% to $7590.0 in Q4 2019 from the same period last year, while for Dec 2020 it was $7590.0, marking a year-over-year change of. This contributed to the annual value of $676100.0 for FY2018, which is 5818.91% up from last year.
  • As of Q4 2019, Sunshine Biopharma's Other financing activities stood at $7590.0, which was down 9892.43% from -$7590.0 recorded in Q2 2019.
  • Sunshine Biopharma's 5-year Other financing activities high stood at $705568.0 for Q4 2018, and its period low was -$411566.0 during Q2 2018.
  • Moreover, its 4-year median value for Other financing activities was $64000.0 (2017), whereas its average is $138907.7.
  • The largest annual percentage gain for Sunshine Biopharma's Other financing activities in the last 5 years was 326180.56% (2018), contrasted with its biggest fall of 74307.19% (2018).
  • Quarter analysis of 4 years shows Sunshine Biopharma's Other financing activities stood at $282800.0 in 2016, then tumbled by 120.05% to -$56700.0 in 2017, then surged by 1344.39% to $705568.0 in 2018, then crashed by 98.92% to $7590.0 in 2019.
  • Its Other financing activities stands at $7590.0 for Q4 2019, versus -$7590.0 for Q2 2019 and $705568.0 for Q4 2018.